1.World Health Organization. Obesity and overweight. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Access 20 Jun 2019.
2.Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. European heart journal. 2015;36(9):551–9.
3.Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. Body Fatness and Cancer—Viewpoint of the IARC Working Group. The New England journal of medicine. 2016;375(8):794–8.
4.Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertension research: official journal of the Japanese Society of Hypertension. 2017;40(12):947–63.
5.Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117(13):1658–67.
6.Katzmarzyk PT, Mire E, Bouchard C. Abdominal obesity and mortality: The Pennington Center Longitudinal Study. Nutr Diabetes. 2012;2:e42.
7.Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. International journal of molecular sciences. 2014;16(1):378–400.
8.Liza K. Phillips JBP. The Link Between Abdominal Obesity and the Metabolic Syndrome. Current Hypertension Reports 2008;10:156–64.
9.Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, Esquivel-Soto J, Morales-Gonzalez A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. International journal of molecular sciences. 2011;12(5):3117–32.
10.Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2007;17(4):319–26.
11.Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013;34(4):463–500.
12.Sam S, Haffner S, Davidson MH, D’Agostino RB, Sr., Feinstein S, Kondos G, et al. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes care. 2009;32(5):932–7.
13.Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116(11):1234–41.
14.Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES–113). Clin Biochem. 2011;44(4):281–7.
15.Huang YM, Dou HL, Huang FF, Xu XR, Zou ZY, Lin XM. Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration. BioMed research international. 2015;2015:564738.
16.Kijlstra A, Tian Y, Kelly ER, Berendschot TT. Lutein: more than just a filter for blue light. Prog Retin Eye Res. 2012;31(4):303–15.
17.Xian-Rong Xu, Zhi-Yong Zou, Xin Xiao, Yang-Mu Huang, Xun Wang, Lin X-M. Effects of lutein supplementation om serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population. Journal of Atherosclerosis and Thrombosis 2013;20:170–7.
18.Wang MX, Jiao JH, Li ZY, Liu RR, Shi Q, Ma L. Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers. Atherosclerosis. 2013;227(2):380–5.
19.McEneny J, Wade L, Young IS, Masson L, Duthie G, McGinty A, et al. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. The Journal of nutritional biochemistry. 2013;24(1):163–8.
20.Palozza P, Parrone N, Simone RE, Catalano A. Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys. 2010;504(1):26–33.
21.Han H, Cui W, Wang L, Xiong Y, Liu L, Sun X, et al. Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression. Lipids. 2015;50(3):261–73.
22.Ford ES, Gillespie C, Ballew C, Sowell A, Mannino DM. Serum carotenoid concentrations in US children and adolescents. The American journal of clinical nutrition. 2002;76(4):818–27.
23.Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52(9):2346–52.
24.Sluijs I, Beulens JW, Grobbee DE, van der Schouw YT. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. The Journal of nutrition. 2009;139(5):987–92.
25.Gao Q, Zhong C, Zhou X, Chen R, Xiong T, Hong M, et al. The association between intake of dietary lycopene and other carotenoids and gestational diabetes mellitus risk during mid-trimester: a cross-sectional study. The British journal of nutrition. 2019:1–22.
26.Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.
27.Xu X-R, Zou Z-Y, Xiao X, Huang Y-M, Wang X, Lin X-M. Effects of Lutein Supplement on Serum Inflammatory Cytokines, ApoE and Lipid Profiles in Early Atherosclerosis Population. Journal of Atherosclerosis and Thrombosis. 2013;20(2):170–7.
28.Yang YX, Wang GY, Pan XC. China Food Composition Table (2nd ed). Beijing: Peking University Medical Press; 2009.
29.United States Department of Agriculture and Agricultural Research Service. USDA Food Composition Database. http://adb.nal.usda.gov/ndb/nutrients/index. Access 11 Jun 2019.
30.Shao A, Hathcock JN. Risk assessment for the carotenoids lutein and lycopene. Regul Toxicol Pharmacol. 2006;45(3):289–98.
31.Zou ZY, Xu XR, Lin XM, Zhang HB, Xiao X, Ouyang L, et al. Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. The British journal of nutrition. 2014;111(3):474–80.
32.Zou Z, Xu X, Huang Y, Xiao X, Ma L, Sun T, et al. High serum level of lutein may be protective against early atherosclerosis: the Beijing atherosclerosis study. Atherosclerosis. 2011;219(2):789–93.
33.Kelli HM, Corrigan FE, 3rd, Heinl RE, Dhindsa DS, Hammadah M, Samman-Tahhan A, et al. Relation of Changes in Body Fat Distribution to Oxidative Stress. Am J Cardiol. 2017;120(12):2289–93.
34.Andersen L, Jacobs DR, Gross MD, Schreiner PJ, Williams DO, Lee D-H. Longitudinal associations between body mass index and serum carotenoids: the CARDIA study. British Journal of Nutrition. 2006;95(2):358–65.